Effect of 7.2% NaCl/6% Hydroxyethyl Starch 200/0.5 Solution on Renal Function during Surgery under Extracorporeal Circulation

Objective: to evaluate the safety of using 7.2% NaCl/6% hydroxyethyl starch 200/0.5 solution to develop acute renal injury (ARI) in patients after aortocoronary bypass surgery (ACBS) under extracorporeal circulation (EC). Subjects and methods. This was a single-center prospective, randomized, single-blind clinical trial. The patients singly received either 7.2% NaCl/6% hydroxyethyl starch 200/0.5 solution (a NC/HES group, n=20) or 0.9% NaCl (a control group, n=20) in a dose of 4 ml/kg for 30 min after induction of anesthesia. The primary endpoint was the rate of ARI diagnosed according to the recommendations of the International Organization KRIGO (Kidney Disease: Improving Global Outcomes). The secondary endpoints were serum cystatin C (sCys С), and urinary neutrophil gelatinase-associated lipocalin (uNGAL). Results. The rate of ARI was comparable in both patient groups. Thus, ARI was found in 4 (20%) patients in the NC/HES group and in 6 (30%) cases in the control group (p=0.72). During the first two postoperative days, the peak concentration of creatinine was significantly lower in the NC/HES group (101 (range 94—107) ^l/l) than in the control one (117 (range 100—127) ^l/l) (p=0.02). That of sCys C was substantially lower in the NC/HES group (0.83 (range 0.73—0.89) mg/l) than in the control one (1.02 (range 0.88—1.15) mg/l) (p=0.001). The patients of the NC/HES group had comparable peak of uNGAL concentrations (33 (range 5—38) ng/ml) versus the controls (30 (range 21—50) ng/ml). Conclusion. The use of NC/HES does not cause any increase in the rate of ARI, increased renal injury, or a more significant decrease in glomerular filtration in patients after ACBS under EC. Key words: hypertonic solution, hydroxyethyl starch, acute renal injury, aortocoronary bypass surgery.

hypertonic solution, hydroxyethyl starch, acute renal injury, aortocoronary bypass surgery

1. Azoubel G., Nascimento B., Ferri M., Rizoli S.Clinics. (Sao Paulo).

2. Schroth M., Plank C., Meissner U., Eberle K.P., Weyand M., Cesnjevar R., DotschJ., Rascher W.Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.Pediatrics.2006; 118 (1): e76—e84.

3. Lomivorotov V.V., Fominskiy E.V., Efremov S.M., Nepomniashchikh V.A., Lomivorotov V.N., Chernyavskiy A.M., Shilova A.N., Karaskov A.M.Hypertonic solution decreases extravascular lung water in cardiac patients undergoing cardiopulmonary bypass surgery.J. Cardiothorac. Vasc. Anesth.2013; 27 (2): 273—282.

4. ЛомиворотовВ.В., ФоминскийЕ.В., НепомнящихВА.Использование гипертонического раствора хлорида натрия при операциях в условиях искусственного кровообращения.Общаяреаниматология.2012; 8 (2): 61—66.

5. Rioux J.P., Lessard M., De Bortoli B., Roy P., Albert M., Verdant C., Madore F., Troyanov S.Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery.Crit. Care Med.2009; 37 (4): 1293—1298.

6. Yunos N.M., Bellomo R., Hegarty C., Story D., Ho L., Bailey M.Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults.JAMA.2012; 308 (15): 1566—1572.

7. Dickenmann M., Oettl T., Mihatsch M.J.Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes.Am. J. Kidney Dis.2008; 51 (3): 491—503.

8. Quilley C.P., Lin Y.S., McGiff J.C.Chloride anion concentration as a determinant of renal vascular responsiveness to vasoconstrictor agents.Br.J. Pharmacol1993; 108 (1): 106—110.

9. Wilcox C.S.Regulation of renal blood flow by plasma chloride.J. Clin. Invest.1983; 71 (3): 726—735.

10. Chowdhury A.H., Cox E.F., Francis S.T., Lobo D.N.A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers.Ann. Surg.2012; 256 (1): 18—24.

11. Reinhart K., Perner A., Sprung C.L., Jaeschke R., Schortgen F., Johan Groeneveld A.B., Beale R., Hartog C.S.; European Society of Intensive Care Medicine.Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients.Intensive Care Med.2012; 38 (3): 368—383.

12. Ronco C., Kellum J.A., Bellomo R.Cardiac surgery-associated acute kidney injury.Int.J. Arif. Organs.2008; 31 (2): 156—157.

13. Moore E.M., Simpson J.A., Tobin A., Santamaria J.Preoperative estimated glomerular filtration rate and RIFLE-classified postoperative acute kidney injury predict length of stay postcoronary bypass surgery in an Australian setting.Anaesth. Intensive Care.2010; 38 (1): 113—121.

14. Bihorac A., Yavas S., Subbiah S., Hobson C.E., Schold J.D., Gabrielli A., Layon A.J., Segal M.S.Long-term risk of mortality and acute kidney injury during hospitalization after major surgery.Ann. Surg.2009; 249 (5): 851—858.

15. Hobson C.E., Yavas S., Segal M.S., Schold J.D., Tribble C.G., Layon A.J., Bihorac A.Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery.Circulation.2009; 119 (18): 2444—2453.

16. Табакъян Е.А., Партигулов СА., Савушкина Т.Н., Лепилин М.Г., Акну-рин Р.С.Гемофильтрация и гемодиализ в профилактике и лечении острой почечной недостаточности после операций на сердце с искусственным кровообращением.Общаяреаниматология.2012; 8 (1): 36—40.

17. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury.Kidney Int.2012; Suppl 2: 1 — 138.

18. Bellomo R., Kellum J.A,, Ronco C.Acute kidney injury.Lancet.2012; 380 (9843): 756—766.

19. Барбараш Л.С., Попков А.Н., Херасков В.Ю., Плотников Г.П., Шуке-вин ДЛ., Григоръев Е.В.Эффективность заместительной почечной терапии при кардиогенном шоке, осложненном полиорганной недостаточностью.Общая реаниматология.2011; 7 (5): 34—37.

20. Ломиворотов В.В., Фоминский Е.В., Непомнящих ВА., Ефремов С.М., Чернявский А.М., Ломиворотов В.Н., Шилова А.Н., Карасъков А.М.

21. Князъкова Л.Г., Ломиворотов В.В., Корнилов И.А., Калининенко А.П.Влияние метилпреднизолона на проницаемость капилляров при операциях в условиях искусственного кровообращения.Общаяреаниматология.2011; 7 (2): 39—44.

22. Rosner M.H., Okusa M.D.Acute kidney injury associated with cardiac surgery.Clin. J. Am. Soc. Nephrol.2006; 1 (1): 19—32.

23. Venkataraman R., Kellum J.A.Prevention of acute renal failure.Chest.2007; 131 (1): 300—308.

24. Kellum J.A., Leblanc M., Gibney R.T., Tumlin J., Lieberthal W., Ronco C.Primary prevention of acute renal failure in the critically ill.Curr. Opin. Crit. Care.2005; 11 (6): 537—541.

25. Kellum J.A., Cerda J., Kaplan L.J., Nadim M.K., Palevsky P.M.Fluids for prevention and management of acute kidney injury.Int.J. Artif. Organs.2008; 31 (2): 96—110.

26. Magder S., Potter B.J., Varennes B.D., Doucette S., Fergusson D.; Canadian Critical Care Trials Group.Fluids after cardiac surgery: a pilot study of the use of colloids versus crystalloids.Crit. Care Med.2010; 38 (11): 2117—2124.

27. Jungheinrich C., Neff T.A.Pharmacokinetics of hydroxyethyl starch.Clin. Pharmacokinet.2005; 44 (7): 681—699.

28. Neuhaus W., Schick MA., Bruno R.R., SchneikerB., Foster C.Y., RoewerN., Wunder C.The effects of colloid solutions on renal proximal tubular cells in vitro.Anesth. Analg.2012; 114 (2): 371—374.

29. De Labarthe A., Jacobs F., Blot F., Glotz D.Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient.Am. J. Med.2001; 111 (5): 417—418.

30. Shaw A.D., Bagshaw S.M., Goldstein S.L., Scherer L.A., Duan M., Schermer C.R., Kellum JA.Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte.Ann. Surg.2012; 255 (5): 821—829.

31. RoosJ.F., DoustJ., Tett S.E., Kirkpatrick C.M.Diagnostic accuracy of cys-tatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children-a meta-analysis.Clin. Biochem.2007; 40 (5—6): 383—391.

32. Dharnidharka V.R., Kwon C., Stevens G.Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis.Am. J. Kidney Dis.2002; 40 (2): 221—226.

33. Mishra J., Ma Q., Prada A., Mitsnefes M., Zahedi K., Yang J., Barasch J., Devarajan P.Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury.J. Am. Soc. Nephrol.2003; 14 (10): 2534—2543.

34. Табакъян Е.А., Партигулов С.А., Лепилин М.Г., Бурмистрова И.В., Водясов В.Д., Коткина Т.И., Титов В.Н.Ранняя диагностика острого повреждения почек при операциях на открытом сердце с искусственным кровообращением.Общаяреаниматология.2013; 9 (1): 51—57.

35. Thakar C.V., Arrigain S., Worley S., Yared J.P., Paganini E.P.A clinical score to predict acute renal failure after cardiac surgery.J. Am. Soc. Nephrol.2005; 16 (1): 162—168.

36. Brunkhorst F.M., Engel C., Bloos F., Meier-Hellmann A., Ragaller M., Weiler N., Moerer O., Gruendling M., Oppert M., Grond S., Olthoff D., Jaschinski U., John S., Rossaint R., Welte T., Schaefer M., Kern P., Kuhnt E., Kiehntopf M., Hartog C., Natanson C., Loeffler M., Reinhart K.; German Competence Network Sepsis (SepNet).Intensive insulin therapy and pentastarch resuscitation in severe sepsis.N. Engl.J. Med.2008; 358 (2): 125—139.